GENE ONLINE|News &
Opinion
Blog

2023-02-01| Special

Biotech Showcase 2023: Digital Medicine Innovation: Its Time is Now

by Justine Zhu
Share To
Over the past three years, the importance and potential of digital healthcare technology have been brought to the forefront. What do investors seek in the next generation of digital healthcare products? In the 2023 Biotech Showcase, the panel, Digital Medicine Innovation: Its Time is Now, examines the current funding trends, showcases the stakeholders' knowledge in evaluating the value of digital therapeutics in healthcare, and delves into where investors are putting their focus. Three professionals broke away from the framework starting from a medical perspective and changed to a consumer and digital product developer perspective to find product positioning and implementation methods.

It's free! Log in now to read

LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top